Prosecution Insights
Last updated: October 25, 2026
Application No. 18/597,579

DEVICES AND METHODS FOR ARTIFICIAL INSEMINATION

Non-Final OA §102
Filed
Mar 06, 2024
Priority
Aug 31, 2018 — provisional 62/725,829 +1 more
Examiner
HALL, DEANNA K
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Inguran LLC
OA Round
1 (Non-Final)
76%
Grant Probability
Favorable
1-2
OA Rounds
6m
Est. Remaining
91%
With Interview

Examiner Intelligence

Grants 76% — above average
76%
Career Allowance Rate
889 granted / 1175 resolved
+5.7% vs TC avg
Strong +15% interview lift
Without
With
+15.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
44 currently pending
Career history
1229
Total Applications
across all art units

Statute-Specific Performance

§101
1.3%
-38.7% vs TC avg
§103
49.6%
+9.6% vs TC avg
§102
32.0%
-8.0% vs TC avg
§112
11.5%
-28.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1175 resolved cases

Office Action

§102
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Information Disclosure Statement The information disclosure statements (IDS) submitted on 3/6/24;8/20/24;1/9/25;7/16/25;4/17/26 are in compliance with the provisions of 37 CFR 1.97(b). Accordingly, the IDSs are being considered by the Examiner. Allowable Subject Matter Claim 6 is objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-5 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Bacich et al. (US 2020/0023162) (“Bacich”). Bacich discloses: A catheter comprising: a first tubular body 18, a second tubular body 30 and a third tubular body 25, the third tubular body axially and slidably extending within the first tubular body (Figs. 1D-F), and the second tubular body axially and slidably extending within the third tubular body (Figs. 1E-F), the third tubular body comprising a proximal end, a distal end and a deflecting element (rounded end, Fig. 1D) at the distal end. further comprising a cervical anchor 19 connected to an outer surface of the first tubular body. the second tubular body 30 is comprised of a polyether block amide; PEBAX®. [0071] (inherent property of PEBAX is a hardness between 30 (Shore D) and 60 (Shore D)) second tubular body having an outer diameter between 1 mm and 3 mm, and an inner diameter between 0.2 mm and 1.5 mm. [0071] Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to DEANNA K HALL whose telephone number is (571)272-2819. The examiner can normally be reached M-F 8:30am- 4:30pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kevin Sirmons can be reached at 571-272-4965. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DEANNA K HALL/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Mar 06, 2024
Application Filed
Aug 04, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12765748
SYSTEMS AND METHODS FOR USE OF A VARIABLE STIFFNESS FLEXIBLE ELONGATE DEVICE
3y 5m to grant Granted Oct 20, 2026
Patent 12766251
FRONT-LOADABLE FLUID TRANSFER ASSEMBLIES AND RELATED MEDICAL FLUID TRANSFER SYSTEMS AND METHODS
3y 4m to grant Granted Oct 20, 2026
Patent 12766267
AUTOINJECTOR
2y 6m to grant Granted Oct 20, 2026
Patent 12759196
SOLID MICRONEEDLE COMPRISING DRUG AND METHOD FOR MANUFACTURING THE SAME
3y 7m to grant Granted Oct 13, 2026
Patent 12758719
SYSTEMS, METHODS, AND APPARATUS FOR LOCATING ACCESS PORT IMPLANTED IN LIVING BODY
2y 7m to grant Granted Oct 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
76%
Grant Probability
91%
With Interview (+15.3%)
3y 2m (~6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1175 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month